Vortioxetine as a potential alternative for patients with escitalopram‐induced jitteriness/anxiety syndrome: A report of three cases
Abstract Background Jitteriness/anxiety syndrome is a recognized adverse effect observed during the initiation or change of dose in antidepressant treatment. Managing patients who develop this syndrome remains a challenge. While escitalopram is a widely used antidepressant known to cause these sympt...
Main Authors: | Kaoru Arai, Mari Nonaka, Shoko Shimada, Masayuki Nakamura |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-12-01
|
Series: | PCN Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/pcn5.158 |
Similar Items
-
Jitteriness/anxiety syndrome caused by coadministration of celecoxib, a selective COX‐2 inhibitor, with escitalopram and trazodone in a patient with depression and spondylolisthesis
by: Toshinori Shirata, et al.
Published: (2023-06-01) -
Impact of Vortioxetine on Synaptic Integration in Prefrontal-Subcortical Circuits: Comparisons with Escitalopram
by: Shreaya Chakroborty, et al.
Published: (2017-10-01) -
Thrombocytopenia due to escitalopram use – A rare case report at the emergency department
by: Cihan Bedel, et al.
Published: (2021-01-01) -
Comparative efficacy and safety of escitalopram, desvenlafaxine, and vortioxetine in the acute treatment of anxious depression: A randomized rater-blinded, 6-week clinical trial
by: K.-S. Oh, et al.
Published: (2022-06-01) -
Reversible Hemifacial Spasm after Starting Escitalopram
by: Mazen Abdulrahaman Basheikh
Published: (2020-03-01)